Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001545:Benserazide / Q000378:metabolism*; D001593:Benzyl Compounds / Q000378:metabolism; D002230:Carbidopa / Q000378:metabolism*; D002394:Catechol O-Methyltransferase / Q000378:metabolism*; D006834:Hydrazines / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D010300:Parkinson Disease / Q000201:enzymology*; D012436:S-Adenosylmethionine / Q000378:metabolism; D013379:Substrate Specificity; D013552:Swine
D001593:Benzyl Compounds; D006834:Hydrazines; D015102:3,4-Dihydroxyphenylacetic Acid; C006307:2,3,4-trihydroxybenzylhydrazine; D001545:Benserazide; D012436:S-Adenosylmethionine; D002394:Catechol O-Methyltransferase; D002230:Carbidopa